Ohno Yasuo | 第一三共安全性研究所
スポンサーリンク
概要
関連著者
-
Ohno Yasuo
第一三共安全性研究所
-
Ohno Yasuo
National Institute of Health Sciences
-
Ohno Yasuo
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Ohno Yasuo
National Inst. Of Health Sci. Tokyo Jpn
-
Sagami Fumio
第一三共安全性研究所
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltd.
-
Sagami Fumio
Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers
-
Sagami Fumio
Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.
-
Hisada Shigeru
Safety Research Department Developmental Research Center, ASKA Pharmaceutical Co., Ltd.
-
Hisada Shigeru
Safety Research Department Developmental Research Center Aska Pharmaceutical Co. Ltd.
-
Hisada Shigeru
Safety Research Department Aska Pharmaceutical Co. Ltd.
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Kai Shuichi
東京都健康安全研究センター
-
Kai Shuichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Sagami Fumio
Japan Pharmaceutical Manufacturers Association (jpma) Qt Prodact
-
Onodera Hiroshi
東京都健康安全研究センター
-
小野寺 博志
Division Of Pathology National Institute Of Health Sciences
-
Onodera Hiroshi
Pharmaceuticals And Medical Devices Agency
-
Yoshida Midori
National Institute of Health Sciences
-
Yoshida Midori
Biological Safety Research Center National Institute Of Health Sciences
-
Yoshida M
National Agricultural Research Center For Hokkaido Region
-
Yoshida Midori
Division Of Pathology National Institute Of Health Sciences
-
Hisada Shigeru
Safety & Pharmacokinetics Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
Shinoda Kazutoshi
Pharmaceuticals and Medical Devices Agency
-
Kawamura Nobuyuki
European Federation of Pharmaceutical Industries and Associations
-
Yamazaki Tsuneyoshi
Kyoritsu University of Pharmacy, Kyoritsu University of Pharmacy
-
Kawai Mutsufumi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufacturers As
-
Yoshida M
Genomic Sciences Center Riken
-
Yoshida Midori
Dept.pathol. Sasaki Inst.
-
Nakazawa Takahiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Urushidani Tetsuro
Toxicogenomics Project National Institute Of Biomedical Innovation:department Of Pathophysiology Dos
-
Urushidani Tetsuro
Laboratory Of Pharmacology & Toxicology Graduate School Of Pharmaceutical Sciences The Universit
-
Matsuda Yuzuru
President Kyowa Hakko Kogyo Co. Ltd.
-
Matsuda Yuzuru
Tokyo Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Onodera H
Pharmaceuticals And Medical Devices Agency
-
Yoshida M
National Food Research Institute
-
Kurokawa Misao
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Sanbuissho Atsushi
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.
-
Yamasaki M
Biofrontier Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
Kawamura Naohisa
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Yamazaki Tsuneyoshi
Kyoritsu University Of Pharmacy Kyoritsu University Of Pharmacy
-
Komori Masayuki
Division Of Analytical Biochemistry Faculty Of Pharmaceutical Sciences Hokkaido University
-
Sanbuissho Atsushi
Medicinal Safety Res. Laboratories Daiichi Sankyo Co. Ltd.
-
Onodera Hiroshi
Dvision Of Pathology Biological Safety Research Center National Institute Of Health Sciences
-
Yoshida M
Kyowa Hakko Kogyo Co. Ltd. Tokyo Jpn
-
Kudo Satoshi
Res. Center Kyorin Pharmaceutical Co. Ltd.
-
Onodera Hiroshi
Pharmaceutical And Medical Devices Agency
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Urushidani Tetsuro
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Nishikawa Akiyoshi
Division of Pathology, National Institute of Health Sciences
-
Komatsu Shinichi
Non-clinical Evaluation Subcommittee Drug Evaluation Committee Japan Pharmaceutical Manufactures Ass
-
INOUE Tadashi
Japan Pharmaceutical Manufactures Association
-
YOSHIDA Midori
Division of Pathology, National Institute of Health Sciences
-
Inoue Tohru
Biological Safety Research Center, National Institute of Health Sciences
-
SANBUISSHO Atsushi
Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Assoc. Drug Evaluation Committee Non-clinical Evaluation Subcommi
-
Kumazawa Toshihiko
Safety Assessment Laboratory Sanwa Kagaku Kenkyusho Co. Ltd.
-
Kumazawa Toshihiko
Pharmaceutical Research Laboratories Sanwa Kagaku Kenkyusho Co. Ltd.
-
Kudo Satoshi
Research Center, Kyorin Pharmaceutical Co., Ltd.
-
Ube Masayuki
Safety Research Laboratory (Kazusa), Mitsubishi Tanabe Pharma Corporation
-
Komatsu Shinichi
Pre-Clinical Development Department, Development & Medical Affairs Division, GlaxoSmithKline K.K.
-
HISADA SHIGERU
Japan Pharmaceutical Manufacturers Association
-
WAKATA AKIHIRO
Japan Pharmaceutical Manufacturers Association
-
Nagao Taku
Food Safety Commission Of Japan
-
Nagao Taku
Laboratory Of Pharmacology & Toxicology Graduate School Of Pharmaceutical Sciences The Universit
-
Nagao Taku
Laboratory Of Pharmacology And Toxicology Graduate School Of Pharmaceutical Sciences The University
-
Ono Atsushi
Toxicogenomics Project National Institute Of Biomedical Innovation:national Institute Of Health Scie
-
Ono Atsushi
Biological Safety Research Center National Institute Of Health Science
-
Kudo Satoshi
Research Center Kyorin Pharmaceutical Co. Ltd.
-
Ube Masayuki
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Yoshida Takemi
Showa Univ.
-
Kiyosawa Naoki
Toxicogenomics Project National Inst. Of Biomedical Innovation
-
Kiyosawa Naoki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Heidel Shawn
Eli Lilly, Eli Lilly and Company
-
Kawakami Koji
Kyoto University
-
Kumagai Yuji
Showa University, School of Pharmaceutical Sciences
-
Inoue Tohru
National Institute of Health Sciences
-
Fueki Osamu
Pharmaceuticals and Medical Devices Agency
-
NAITO Shinsaku
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
FURUTA Shigeru
Japan Pharmaceutical Manufacturers Association, Drug Evaluation Committee, Non-clinical Evaluation S
-
KITADA Mitsukazu
Chiba University Hospital
-
UNNO Takashi
Pharmaceutical Research and Manufactures of America
-
Nishikawa Akiyoshi
Division Of Pathology Biology Safety Research Center National Institute Of Health Sciences
-
Sanbuissyo Atsushi
Medical Safety Research Laboratories, R & D Division, Daiichi-Sankyo Co., Ltd.
-
Takahashi Michihito
Pathology Peer Review Center
-
Yoshida Midori
National Agricultural Research Center For Hokkaido Region
-
Kawakami Koji
Dep. Of Pharmacoepidemiology Graduate School Of Medicine And Public Health Kyoto Univ.
-
Miwa Satoko
Exploratory Toxicology & Dmpk Research Laboratories Tanabe Seiyaku Co. Ltd.
-
MIYAGISHIMA Toshikazu
Toxicogenomics Project, National Institute of Biomedical Innovation
-
URUSHIDANI Tetsuro
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Kimura Kazuya
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Komatsu Shinichi
Pre-clinical Development Department Development & Medical Affairs Division Glaxosmithkline K.k.
-
Suzuki Takamasa
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Urushidani Tetsuro
Laboratory Of Pharmacology And Toxicology Graduate School Of Pharmaceutical Sciences The University
-
Miyagishima Toshikazu
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Inoue Tadashi
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Fueki Osamu
Pharmaceuticals And Medical Devices Agency Shin-kasumigaseki Building
-
Kumagai Yuji
Showa University School Of Pharmaceutical Sciences
-
Heidel Shawn
Eli Lilly Eli Lilly And Company
-
Uehara Takeki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Furuta Shigeru
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Wakata Akihiro
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
OMURA Ko
Toxicogenomics Project, National Institute of Biomedical Innovation
-
HIRODE Mitsuhiro
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Omura Ko
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Shimuzu Toshinobu
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Ohno Yasuo
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Yoshida Takemi
Showa University School Of Pharmaceutical Sciences
-
Kumazawa T.
Pharmaceutical Research Laboratories Sanwa Kagaku Kenkyusho Co. Ltd.
-
Naito Shinsaku
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-clinical Evaluation Sub
-
Inoue Tohru
Biological Safety Research Center National Institute Of Health Sciences
-
Sagami Fumio
Drug Safety Research Laboratories Eisai Co. Ltb.
-
Hirode Mitsuhiro
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Inoue Tohru
National Institute Of Health Science
-
Yamada Hiroshi
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Ono Atsushi
Biological Safety Research Center National Institute Of Health Sciences
-
NAKATSU Noriyuki
Toxicogenomics Project, National Institute of Biomedical Innovation
-
IGARASHI Yoshinobu
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Igarashi Yoshinobu
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Nakatsu Noriyuki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Noriyuki Nakatsu
Toxicogenomics Project, National Institute of Biomedical Innovation
著作論文
- Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats
- Morphological characterization of the ovary under normal cycling in rats and its viewpoints of ovarian toxicity detection
- Safety assessment of biopharmaceuticals : Japanese perspective on ICH S6 guideline maintenance
- CURRENT OPINION : SAFETY EVALUATION OF DRUG METABOLITES IN DEVELOPMENT OF PHARMACEUTICALS
- Gene expression profiling in rat liver treated with various hepatotoxic-compounds inducing coagulopathy
- Evaluation of DNA microarray results in the Toxicogenomics Project (TGP) consortium in Japan